![]() |
市場調查報告書
商品編碼
1854892
眼表面疾病調查報告(2025年)2025 Ocular Surface Disease Survey Report |
||||||
Market Scope 於 2025 年 7 月至 8 月期間,對美國和西歐的眼科醫生和驗光師進行了調查,以了解他們接診的患者情況、眼表疾病篩檢、治療方案的採用情況以及最新的市場趨勢。
我們邀請了在 market-scope.com 網站上註冊的眼科公司和涵蓋大多數專科(白內障、屈光不正、視網膜、乾眼症/青光眼和普通眼科)的驗光師參與我們這項年度贊助調查。
我們於 2025 年 7 月 25 日發出邀請,並於 8 月 8 日最終聯繫了受訪者。我們收到了來自美國 158 位受訪者和澳洲 40 位受訪者的回复,共 198 位受訪者。所有結果均以受訪者人數計算。並非所有問題都適用於所有供應商,因此受訪者人數 (n) 可能在整個調查過程中有所變化。
本調查報告僅為所報告數據的總結分析,並不試圖推斷整個市場的情況。所有調查資料均已匿名化處理,並儲存於安全伺服器上。
本調查中的問題由 MarketScope 與本調查的贊助商合作制定。問題包括但不限於:
Market Scope surveyed ophthalmologists and optometrists in the US and Western Europe (WE) during July and August 2025 to measure patients they were seeing and screening for ocular surface disease; adoption of treatments; and insight into the latest market trends.
Ophthalmologists and optometrists from most specialties (cataract, refractive, retina, dry eye glaucoma, and comprehensive) who self-registered on market-scope.com were invited to participate in the annual sponsored survey.
An email invitation was sent on July 25, 2025, and a last call went out on Aug. 8, 2025. We received 198 total complete, unique responses - 158 from the US and 40 from WE. All results were calculated based on respondent count; because not all questions were applicable to all providers, the respondent count (n) may vary throughout the survey.
Survey reports are strictly a summary analysis of the reported data, and no additional extrapolation to the overall market was performed. All survey data are de-identified and maintained on a secure server.
Questions included in the survey were developed by Market Scope in combination with companies that sponsor the survey. Question topics included, but were not limited to, the following: